Story perspectives

New Blood Test Detects Pancreatic Cancer with 91.9% Accuracy

2/4/2026

Summary

Story summary

Researchers at the University of Pennsylvania report a four-marker blood test for early pancreatic cancer detection.
Two new biomarkers, ANPEP and PIGR, join existing markers to improve detection.
The four-marker test achieves 91.9% accuracy in distinguishing cancer patients from healthy individuals and those with non-cancerous conditions.
Experts say larger population validation is needed before using the test to screen high-risk individuals, particularly in the UK.

1 of 1

Story summary

Researchers at the University of Pennsylvania report a four-marker blood test for early pancreatic cancer detection.
Two new biomarkers, ANPEP and PIGR, join existing markers to improve detection.
The four-marker test achieves 91.9% accuracy in distinguishing cancer patients from healthy individuals and those with non-cancerous conditions.
Experts say larger population validation is needed before using the test to screen high-risk individuals, particularly in the UK.